US Acne and Rosacea Market 2019 Growth Drivers, Key Trends & Developments, Company Profiles (Bausch Health Companies, Allergan, Foamix Pharmaceuticals and Sol-Gel Technologies) Analysis

Latest niche market study on "US Acne and Rosacea Market: Industry Analysis and Outlook (2018-2022)" pblished with OrbisResearch.com

Acne and Rosacea are the most common dermatological disorders affecting people in the United States. Acne is a chronic skin disorder in which the hair follicles become blocked and/or inflamed, which is most prevalent among teenagers. However, some people may suffer from acne well into their 30s and 40s even. Acne can occur in forms ranging from comedones to cystic lesions, depending upon severity.

Rosacea is a common skin condition that causes redness and visible blood vessels on the nose, cheeks, and forehead. Rosacea can occur to anyone. But it is most commonly affects adults over age 30, particularly women with fair skin. The condition of rosacea is increasingly widespread in the U.S. and affecting approximately 16 million population in the country.

Request a sample @ https://www.orbisresearch.com/contacts/request-sample/2458243

Topical drugs currently dominate both markets in the U.S. Systemic medications such as oral antibiotics, hormonal agents or other drugs are also used for the treatment of acne and rosacea. The ongoing development of new drugs is expected to witness an extraordinary growth rate due to higher efficacy, convenient dosing and fewer side effects.

The increase in emotional burden due to these skin conditions is a key factor driving the growth of the market. Growing awareness regarding rosacea and acne treatment options has significantly driven the market in the U.S. Rising purchasing power and mounting healthcare expenditure has also fuelled the growth of the market in the region. Despite being common skin disorders, advancement in treatment has been limited over the past years exhibiting a great opportunity of growth in the future. The companies are developing new treatment options, in which, most products are in late-stage indicating an optimistic future for the market

The report “U.S. Acne & Rosacea Market: Industry Analysis & Outlook (2018-2022)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S. market. The report profiles the key players of the market including Bausch Health Companies, Allergan, Foamix Pharmaceuticals and Sol-Gel Technologies.

Browse the full report @ https://www.orbisresearch.com/reports/index/us-acne-and-rosacea-market-industry-analysis-and-outlook-2018-2022

Some points from Table of Contents:
1. Market Overview
1.1 Acne
1.1.1 Acne Overview
1.1.2 Causes & Symptoms of Acne
1.1.3 Classification of Severity
1.1.4 Treatment for Acne
1.1.5 Acne Treatment Continuum
1.1.6 Limitations of Acne Treatments
1.2 Rosacea
1.2.1 Rosacea Overview
1.2.2 Symptoms and Causes of Rosacea
1.2.3 Treatment for Rosacea
2. The U.S. Acne Market
2.1 The U.S. Acne Market Forecast by Value
2.2 The U.S. Acne Market by Drug Type
2.3 The U.S. Acne Topical Drugs by Brand
2.4 The U.S. Acne Oral Antibiotics by Brand
2.5 The U.S. Acne Market Forecast by Product
2.5.1 The U.S. Minocycline Revenue Forecast
2.5.2 The U.S. Retin-A Generics Revenue Forecast
2.5.3 The U.S. Epiduo/Epiduo Forte Revenue Forecast
2.5.4 The U.S. Aczone Revenue Forecast
2.5.5 The U.S. Onexton Revenue Forecast
2.5.6 The U.S. Solodyne Revenue Forecast
2.5.7 The U.S. Oracea Revenue Forecast
2.5.8 The U.S. Ziana Revenue Forecast
2.6 The U.S. Acne Prevalence Forecast
2.7 The U.S. Acne Addressable Population
2.7.1 The U.S. Acne Addressable Population Forecast
2.7.2 The U.S. Acne Addressable Population by Severity
2.7.3 The U.S. Acne Mild Population Forecast
2.7.4 The U.S. Acne Moderate Population Forecast
2.7.5 The U.S. Acne Severe Population Forecast
2.8 The U.S. Acne Topical Treatment Population
2.8.1 The U.S. Acne Topical Treatment Population Forecast
2.8.2 The U.S. Acne Topical Treatment Population by Severity
2.8.3 The U.S. Acne Topical Treatment Mild Population Forecast
2.8.4 The U.S. Acne Topical Treatment Moderate Population Forecast
2.8.5 The U.S. Acne Severe Topical Treatment Population Forecast
2.9 FMX101
2.9.1 The U.S. FMX-101 Drug Patient Population Forecast
2.9.2 The U.S. FMX-101 Drug Market Share Forecast
2.9.3 The U.S. FMX-101 Drug Cost Forecast
2.9.4 The U.S. FMX-101 Drug Revenue Forecast
2.10 TWIN
2.10.1 The U.S. TWIN Drug Patient Population Forecast
2.10.2 The U.S. TWIN Drug Market Share Forecast
2.10.3 The U.S. TWIN Drug Cost Forecast
2.10.4 The U.S. TWIN Drug Revenue Forecast
2.11 SIRS-T
2.11.1 The U.S. SIRS-T Drug Patient Population Forecast
2.11.2 The U.S. SIRS-T Drug Market Share Forecast
2.11.3 The U.S. SIRS-T Drug Cost Forecast
2.11.4 The U.S. SIRS-T Drug Revenue Forecast

Direct purchase a single user copy @ https://www.orbisresearch.com/contact/purchase/2458243

Check the List of Tables:
Types of Acne
Treatment for Acne
Types of Rosacea
Treatment for Rosacea
The U.S. Acne Market Forecast by Value (2017-2022)
The U.S. Acne Market by Drug Type (2017)
The U.S. Acne Topical Drugs by Brand (2017)
The U.S. Acne Oral Antibiotics by Brand (2017)
The U.S. Minocycline Revenue Forecast (2017-2022)
The U.S. Retin-A Generics Revenue Forecast (2017-2022)
The U.S. Epiduo/Epiduo Forte Revenue Forecast (2017-2022)
The U.S. Aczone Revenue Forecast (2017-2022)
The U.S. Onexton Revenue Forecast (2017-2022)
The U.S. Solodyne Revenue Forecast (2017-2022)
The U.S. Oracea Revenue Forecast (2017-2022)
The U.S. Ziana Revenue Forecast (2017-2022)
The U.S. Acne Prevalence Forecast (2017-2022)
The U.S. Acne Addressable Population Forecast (2017-2022)
The U.S. Acne Addressable Population by Severity (2017)
The U.S. Acne Mild Population Forecast (2017-2022)
The U.S. Acne Moderate Population Forecast (2017-2022)
The U.S. Acne Severe Population Forecast (2017-2022)
The U.S. Acne Topical Treatment Population Forecast (2017-2022)
The U.S. Acne Topical Treatment Population by Severity (2017)
The U.S. Acne Topical Treatment Mild Population Forecast (2017-2022)
The U.S. Acne Topical Treatment Moderate Population Forecast (2017-2022)
The U.S. Acne Severe Topical Treatment Population Forecast (2017-2022)
The U.S. FMX-101 Drug Patient Population Forecast (2020-2024)
Continued...

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: sales@orbisresearch.com
Follow Us on Linkedin: https://www.linkedin.com/company/orbis-research

This release was published on openPR.